SelectScience
Join Free
Accelerating Science
NewsClinical Diagnostics

Secarna Pharmaceuticals to collaborate with Guangzhou’s Sun Yat-sen University to develop a treatment for COVID-19

Secarna Pharmaceuticals
27 Apr 2020
Edward Carter
Publishing / Media

Industry news

Secarna Pharmaceuticals have announced that it has entered into a cooperation with the First Affiliated Hospital at Guangzhou Sun Yat-sen University (SYSU) for the development of a treatment or prophylactic for SARS-CoV-2 viral infections. Under this agreement, Secarna will employ its proprietary LNAplusTM platform to develop antisense oligonucleotides (ASOs) which specifically suppress the expression of a certain host factor that is essential for the viral infection cycle.

Secarna’s approach to target host factors is beneficial compared to other approaches targeting the virus directly, as most viruses are known to evade targeted therapies by mutation over time. This risk could be completely avoided by targeting host factors. Additionally, different viruses often depend on common host factors. Therefore, a therapy addressing a host factor linked to existing or emerging viruses could potentially also serve as a treatment against future challenges.

The feasibility of Secarna’s concept was already successfully demonstrated in 20191. In this study, Secarna employed its LNAplusTM platform to develop ASOs targeting the host factor NPC1 to efficiently reduce Ebola virus infection in vitro. The approach’s applicability to SARS-CoV-2 is currently being evaluated by Prof. Claus Bachert at the University of Ghent in Belgium and the First Affiliated Hospital at Guangzhou Sun Yat-sen University (SYSU).

“We are very excited to be working together with Guangzhou’s Sun Yat-sen University and leveraging our proprietary technology to develop LNAplusTM-based ASOs to potentially tackle SARS-CoV-2 infections. By targeting a host factor essential to the viral infection cycle, we hope to prevent the infection of cells and viral spread,” said Jonas Renz, Managing Director and Co-founder of Secarna Pharmaceuticals.

Prof. Claus Bachert added: “This international cooperation is combining an innovative development platform with specific translational laboratory skills and the access to patients in a unique way.”

Want more of the latest sciences news straight to your inbox? Become a SelectScience member for free today>>

Links

Secarna Pharmaceuticals

Tags

ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Respiratory InfectionsRespiratory infections are caused by pathogens such as bacteria, viruses, and fungi, leading to diseases like pneumonia, tuberculosis, and COVID-19. It is important to identify respiratory infections quickly in patients to ensure appropriate treatment and care, and to prevent sepsis. Browse our peer-reviewed product directory to find the best tools for respiratory infection detection, compare products, check reviews, and get pricing directly from manufacturers.VirusesViruses are microscopic pathogens that require a host cell to replicate. Understanding their structure, replication cycle, and impact on the immune system is crucial in developing effective treatments, vaccines, and diagnostic methods. Research continues to focus on emerging viral diseases and antiviral drug discovery. Explore solutions for virus research, detection, and treatment in our peer-reviewed product directory; compare products, check customer reviews, and get pricing directly from manufacturers.CoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.

Related articles